Antisense inhibition of parathyroid hormone-related peptide gene expression reduces malignant pituitary tumor progression and metastases in the rat

Cancer Research

Volumn 56, Issue 1, 1996, Pages 77-86

  Akino, Kozu ^a   Ohtsuru, Akira ^a   Yano, Hiroki ^a   Ozeki, Shin Ichiro ^a   Namba, Hiroyuki ^a   Nakashima, Masahiro ^a   Ito, Masahiro ^a   Matsumoto, Takaaki ^b   Yamashita, Shunichi ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYCLOPHILIN; PARATHYROID HORMONE RELATED PROTEIN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HYPOPHYSIS TUMOR; MALIGNANT TRANSFORMATION; METASTASIS POTENTIAL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; SURVIVAL RATE;

ANIMALS; BASE SEQUENCE; CELL DIVISION; FEMALE; GENE EXPRESSION; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; OLIGONUCLEOTIDES, ANTISENSE; PARATHYROID HORMONE; PARATHYROID HORMONE-RELATED PROTEIN; PITUITARY NEOPLASMS; PROTEINS; RATS; TUMOR CELLS, CULTURED;

EID: 0030031660     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Yamashita, S., Ohtsuru, A., Ito, M , Ng, W Y., Villadolid, M. C., Enomoto, H., Usa, T., Akino, K., Tanigawa, K , Tsukazaki, T., Ozeki, S., Namba, H., Ito, H., Yoshimura, T. and Nagataki, S. Cytokine expression in pituitary tumors. In: S. Melmed (ed.), Molecular and Clinical Advances in Pituitary Disorders 1993. Los Angeles: Endocrine Research Education Inc., 1993.
2. Melmed, S. Acromegaly, N. Engl J Med , 322: 966-977, 1990.
3. Lyons, J., Landis , C. A., and Harsh., G. Two G protein oncogenes in human endocrine tumors. Science (Washington DC), 249: 635-639, 1990.
4. Mulligan, L M., Kwok, J B J., Healey, C. S , Elsdon, M J., Eng, C., Gardner, E., Love, D. R, S. E., M., Moore, J. K., Papi, L., Ponder, M. A., Telenius, H., Tunnacliffe, A., and Ponder, B. A. Germline mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature (Lond), 363: 458-460, 1993
5. Parma, J., Duprez, L., Sande, V., Cochaux, P., Gervy, C., Mockel, J., Domont, J., and Vassart, G Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature (Lond.), 365: 659-651, 1993.
6. Herman, V., Drazin, N. Z, Gonsky, R., and Melmed, S. Molecular screening of pituitary adenomas for gene mutations and rearrangements. J. Clin. Endocrinol. Metab., 77: 50-55, 1993.
7. Fagin, J. A., Matsuo, K., Karmarker, A., Chen, D. L , Tang, S-H., and Koeffler, H. P. High prevalence of mutations of the p53 gene in poorly differentiated thyroid carcinomas. J. Clin. Endocrinol. Metab , 91: 179-184, 1993.
8. Cryns, V. L., Thor, A., Xu, H J., Hu, S X., Wierman, M. E., Vickery, A. L . Benedict, W. F , and Arnold, A. Loss of the retinoblastoma tumor suppressor gene in parathyroid carcinoma. N. Engl. J Med., 330: 651-659, 1994.
9. Cryns, V. L , Rubio, M., Thor, A., Louis, D. N., and Arnold, A. p53 abnormalities in human parathyroid carcinoma. J Clin. Endocrinol Metab., 78: 1320-1324, 1994.
10. Strewler, G. J., Stern, P. H., Jacobs, J. W., Eveloff, J., Klein, R. F., Leung, S. C., Rosenblatt, M , and Nissenson, R. A. Parathyroid hormone-like protein from human renal carcinoma cells. J. Clin Invest., 80: 1803-1807, 1987.
11. Moseley, J. M., Kubota, M , Diffenback-Jagger, H., Wettenhall, R. E. H., Kemp, B., Suva, L J., Rodda, C. P., Ebeling, P. R., Hedson, P. J., Eajac, J. D., and Martin, T. J. Parathyroid hormone-related protein purified from a human lung cancer. Proc. Natl. Acad. Sci USA, 84: 5048-5052, 1987
12. Margin, M., Ikeda, K., Dreyer, B. E., and Broadus, A E Isolation and characterization of the human parathyroid homone-like peptide gene. Proc. Natl. Acad. Sci USA, 86: 2408-2412, 1989.
13. Urena, P., Kong, X F., Abou-Samra, A., Juppner, H., Kronenberg, H. M , Potts, J. T., and G. V., S. Parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acids are widely distributed in rat tissues. Endocrinology, 133: 617-623, 1993.
14. Ikeda, K., Weir, E. C., Mangin, N., Dannies, P. S., Kinder, B., Deftos, L. J., Brown, E M., and Broadus, A E. Expression of messenger ribonucleic acids encoding a parathyroid hormone-like peptide in normal human and animal tissues with abnormal expression in human parathyroid adenomas. Mol. Endocrinol., 2: 1230-1236, 1988.
15. Asa, S. L., Henderson, J , Goltzman, D., and Drucker, D. J. Parathyroid hormone-like peptide in normal and endocrine tissues. J. Clin. Endocrinol Metab., 71: 1112-1118, 1990.
16. Ito, M., Enomoto, H., Usa, T., Villadolid, M C , Ohtsuru, A., Namba, H., Sekine, I., and Yamashita, S. Expression of parathyroid hormone-related peptide in human pituitary tumors J. Clin. Pathol., 46: 682-683, 1993
17. Nakashima, M , Ohtsuru, A. Lou, W., Nakayama, T , Enomoto, H., Usa, T., Kiriyama, T., Ito, M., Nagataki, S., Yamashita, S., and Sekine, I Expression of parathyroid hormone-related in human thyroid tumors. J. Pathol., 175: 227-236, 1995.
18. Vargas, S J., Gillespie, M. T., Powell, G. J., Southby, J., Danks, J. A., Moseley, J M., and Martin, T. J. Localization of parathyroid hormone-related protein mRNA expression in breast cancer and metastatic lesions by in situ hybridization. J. Bone Mineral Res., 7: 971-9, 1992.
19. Hayashi, I., and Sato, G. H. Replacement of serum by hormones permits growth of cells in a defined medium. Nature (Lond.), 259: 132-134, 1976.
20. Serri, L. Rasio, E , and Beauregard, H Recurrence of hyperproplactinemia after selective transsphenoidal adenomectomy in woman with prolactinoma. N. Engl. J. Med , 309: 280-283, 1983.
21. Tashijian, A. J. J. Clonal strains of hormone-producing pituitary cells. Methods Enzymol Cell Culture, 58: 527-535, 1979.
22. Enomoto, H., Yamashita, S., Usa, T., Namba, H., Ohtsuru, A , Villadolid, M. C., Tsukazaki, T., Matsumoto, T , and Iwasaki, K. Autocrine/paracrine function of parathyroid hormone-related peptide in rat osteoblast-like cells Biochem Biophys. Res. Commun, 191: 1261-1269, 1993.
23. Chirgwin, J. M., Pizybyla, A E , MacDonald, R. J., and Rutter, W. J. Isolation of biologically active rebonucleic acid from sources enriched in ribonuclease Biochemistry, 191: 1261-1269, 1979.
24. Juppner, H. Abou, S A , Freeman, M., Kong, X F , Schipani, E., Richards, J , Kolakowski, L. J , Hock, J., Potts, J. J., Kronenberg, H. M , and Segre, G. V. A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science (Washington DC), 254: 1024-6, 1991
25. Danielson, P. E., Forss-Petter, S , Brow, M. A. Calavetta, L., Douglass, J., Miler, R. J., and Sutcliffe, J. G. pIB15: a cDNA clone of the rat mRNA encoding cyclophilin. DNA, 7: 261-267, 1988.
26. Yasuda, T., Banville, D , Rabbani, S A., Hendy, G. N., and Goltzman, D Rat parathyroid hormone-like peptide: comparison with the human homologue and expression in maliganant and normal tissue. Mol. Endocrinol, 3 518-525, 1989.
27. Nakayama, T., Ohtsuru, A , Enomoto, H., Namba, H., Ozeki, S., Shibata, Y., Yokota, T., Nobuyoshi, M., Ito, M., Sekine, I , and Yamashita, S Coronary atherosclerotic smooth muscle cells overexpress human parathyroid hormone-related peptide. Biochem Biophys. Res. Commun., 200: 1028-1035, 1994.
28. Leone, A., Flatow, U , King, C. R., Sandeen, M A., Margulies, I M K., Liotta, L. A , and Steeg, P. S. Reduced tumor incidnece, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell, 65: 25-35, 1991.
29. Ushiroda, Y , Katagami, H , Hirabayashi, M., Yonekawa, T., Osamura, R. Y., Yuki, A. and Matsukura. S Increased expression of parathyroid hormone-related protein (PTHrP) in the pituitary adenoma of human growth hormone (GH)-releasing factor (GRF) transgenic rats (Tg). 76th Annual Meeting of Endocrine Society, Abstract: 534, 1994.
30. Li, X., and Drucker, D. J Parathyroid hormone-related peptide is a downstream target for ras and src activation. J. Biol. Chem., 269: 6263-6266, 1994.
31. Guo, X., Zhang, P., Mitchell, D. A , Denhardt, D. T., and Chanbers, A. F Identification of a ras-activated enhance in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activated correlates with the metastatic potential of the cell Mol. Cell. Biol., 15: 476-487, 1995.
32. Pei, L , Melmed, S , Scheithauer, B., Kovacs, K. and Prager, D. H-ras mutations in human pituitary carcinoma metastasis. J Clin Endocrinol. Metab., 78: 842-846, 1994
33. Hongo, T , Kupfer, J., Enomoto, H., Shanfi, B , Giannella-Neto, D., Forrester, J. S., Singer, F. R., Goltzman, D , Hendy, G N , Pirola, C , Fagin, J. A., and Clemens, T L. Abundant expression of parathyroid hormone-related primary rat aortic smooth muscle cells accompanies serum-induced proliferation. J Clin Invest., 88: 1841-1847, 1991
34. Rodan, S. B., Wesolowski, G , Ianacone, J., Thiede, M A., and G. A., R. Production of parathyroid hormone-like peptide in a human osteosarcoma cell line: stimulation by phorbol esters and epidermal growth factor. J. Endocrinol., 122: 219-227, 1989.
35. Kiriyama, T., Gillespie, M T , Glatz, J. A., Fukumoto, S., Moseley, J. M., and Martin, T. J. Transforming growth factor β stimulation of parathyroid hormone-related peptide (PTHrP): a paracrine regulator? Mol. Cell. Endocrinol., 92: 55-62, 1993.
36. Welch, D. R., Fabra, A., and Nakajima, M. Transforming growth factor-β stimulates mammary adenocarcinoma cell invasion and metastatic potential Proc. Natl. Acad. Sci. USA, 87: 7678-7682, 1990.
37. Lound-Johansen, M., Bjerkvig, R., and Humphrey, P. A. Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro. Cancer (Phila.), 50: 6039-6044, 1990
38. Günther, U , Hofmann, M., Rudy, W., Seber, S., Söller, M., Haussmann, I., Matzku, S., Wenzel, A., Ponta, H., and Herrilich, P. A new variant of glycoprotein CD44 congers metastatic potential to rat carcinoma cells. Cell, 65: 13-24, 1991.
39. Schalken, J. A., Ebeling, S. B., and Isaacs, T. J. Downmodulation of fibronectin mRNA in metastasizing rat prostatic cancer cells revealed by differential hybridization analysis. Cancer Res., 48: 2042-2046, 1988.
40. Kato, Y., Nakayama, Y., Uneda, M., and Miyazaki, K. Induction of 103-kDa gelatinase/type IV collagenase by acidec culture conditions in mouse metastatic melanoma cell lines. J. Biol. Chem., 267: 11424-11430, 1992.
41. Noda, M., and Rodan, G. A Transcriptional regulation of osteopontin production in rat osteoblast-like cells by parathyroid hormone. J. Cell Biol., 108: 713-718, 1989.
42. Babich, M., and Foti, L. R. E-cadherins identified in osteoblastic cells: effects of parathyroid hormone and extracellular calcium on locomotion. Life Sci., 54: 201-208, 1994
43. Krieg, A. M., Yi, A-K , Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., and Klinman, D. M. CpG motif in bacterial DNA trigger direct B-cell activation. Nature (Lond.), 374: 546-549, 1995
44. Kaiser, S M., Lanevrille, P., Bernier, S. M., Rhim, J. S., Kremer, R., and Goltzman, D Enhanced growth of a human keratinocyte cell line induced by antisense RNA for parathyroid hormone-related peptide. J. Biol. Chem , 267: 13623-13628, 1992.
45. Karaplis, A. C., Luz, A., Glowacki, J., Bronson, R. T., Tybulewics, V. L., Kronenberg, H. M., and Mulligan, R. C. Lethal skeletal dysplasia from targeted disruption of the parhtyroid hormone-related peptide gene Genes & Dev , 8: 277-278, 1994.
46. Long, L., Rubin, R , Baserga, R., and Brodt, D. Loss of metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor receptor. Cancer Res., 55: 1006-1009, 1995.
47. Resnicoff, M , Abraham, D., Yutanawiboonchai, W., Rotman, H. L., Kajstura, J., Rubin, R., Zoltick, P., and Baserga, R. The insulin-like growth factor 1 receptor protects tumor cells from apoptosis in vivo. Cancer Res., 55: 2463-2469, 1995.
48. - T cells by B7 transfected melanoma cells. Science (Washington, DC), 259: 368-370, 1993
49. Triojan, J., Johnson, T. R., Rudin, W S. D., Ilan, J., Tykocinski, M. L., and Ilan, J. Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Science (Washington, DC), 259: 94-97, 1993.
50. Kitajima, I., Shinohara, T., Bilakovics, J., Brown, D. A., Xu, X., and Nerenberg, M Ablation of transplanted HTLV-1 TAX transformed tumors in mice by antisense inhibition of NF-κ, Science (Washington DC), 258: 1792-1795, 1991.
51. Nesterova, M., and Yoon, S. C-C. A single-injection protein kinase A-directed antisense treatment to inhibit tumor growth. Nature Med., 1: 528-533, 1995.
52. Hijiya, N., Shang, J., Ratajczak, Z., Kant, J. A., Deriel, K., Herlya, M., Zon, G , and Gewritz, A. M. Biological and therapeutic significance of MYB expression in human melanoma. Proc. Natl. Acad. Sci. USA, 91: 4499-4503, 1994.